Delivery Order SPE2DE24D0013-SPE2D626F4508
- Not listed
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,040 on October 23, 2025, by the Defense Logistics Agency Medical Supply Chain. The award, designated as contract number 4569817308 for XPCOV2/FLU/RSV-10 products, utilizes a firm fixed-price delivery order structure with no set-aside designation and carries an ultimate completion date of October 30, 2025. This delivery order represents work performed at...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a $4,198.65 firm fixed-price delivery order from the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for the delivery of diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with an ultimate completion date of September 19, 2025. This contract award carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F4508Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California, with an ultimate completion date of October 30, 2025. No small business set-aside was used for this procurement, reflecting Cepheid's established competitive position as a primary federal supplier of molecular diagnostic solutions. This delivery order is consistent with Cepheid's extensive portfolio of federal contracts supporting diagnostic capabilities across multiple agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and the U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at approximately $6.7 million and $32.8 million respectively, which serve as the primary contracting vehicles for supplying molecular diagnostic reagents, test kits, and associated services to support federal healthcare operations. The firm fixed-price structure and product designation align with Cepheid's core competency in providing rapid molecular diagnostic testing for infectious diseases and clinical conditions through its established GeneXpert diagnostic platform.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 10/23/25 |